Browse All

Current Filters

CLEAR FILTER x

TITLE

Impact of Early Fremanezumab Initiation and Treatment Pauses on the Reduction of Monthly Migraine Days: Analyses from the PEARL Study

Author:Pavão Martins, Isabel   Mitsikostas, Dimos Dimitrios   Tassorelli, Cristina   Kokturk, Pinar   Zuppone, Stefania   Ortega, Mario   Bryson, Juline   Ramirez Campos, Verena   

Session Name:P10: Headache: Pharmacological Migraine Prevention 2  

Topic:Headache  

Program Number:P10.007  

Author Institution:Centro de Estudos Egas Moniz, Faculty of Medicine, University of Lisbon, Lisbon, Portugal, Portugal  Department of First Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece  Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy  IRCCS C. Mondino Foundation, Pavia, Italy, Italy  Teva Netherlands B.V., Haarlem, The Netherlands, Netherlands  Teva Pharmaceutical Industries Ltd, Parsippany, NJ, USA, Parsippany, NJ  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, West Chester, PA  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, PA